Delivery Order SPE2DB20D2104-SPE2DB25FMPCF
- Not listed
- The Defense Logistics Agency awarded a $45,549.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This non-competitive delivery order, issued on April 24, 2025 with an ultimate completion date of April 25, 2025, represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is classified as a...
- The Defense Logistics Agency awarded a $33,187.59 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This firm fixed-price contract, awarded on June 25, 2025, with completion scheduled for June 26, 2025, represents a routine pharmaceutical procurement under the agency's medical supply chain operations. The award carries no set-aside designation, indicating competitive procurement from the open market. AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,459.01 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This firm fixed price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by April 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,313.78 to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This competitively awarded, firm fixed-price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract carries no set-aside designation, reflecting open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,925.06 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, under a firm fixed-price contract type with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a $52,988.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication used for stroke prevention and blood clot treatment. This non-set-aside competitive award, issued on September 8, 2025, with completion targeted for September 9, 2025, represents a routine pharmaceutical supply delivery to support federal healthcare requirements. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,065.95 for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order from...
- The Defense Logistics Agency awarded a delivery order valued at $6,506.70 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The order was competitively awarded as a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of June 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,835.51 to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract is classified as a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $40,479.71 to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and was competitively awarded without set-aside restrictions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMPCFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication, with a contract ceiling value of $12,841.34. The award, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, utilizes firm fixed pricing and represents a non-competitive, non-set-aside procurement. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical requirements through open competition. This specific delivery order represents routine fulfillment of the company's responsibilities under its prime IDC to provide medications supporting military personnel and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 4/22/25 |